Neuromod

Description

Neuromod develops and commercializes Lenire, an FDA‑approved bimodal neuromodulation medical device for tinnitus, publishes peer-reviewed clinical trials, provides clinician training and partner support, and operates manufacturing and global distribution for Lenire.

Neuromod is located in the Dublin ecosystem.

Related

• CimCureCimCure develops conjugate cancer vaccines that induce antibody responses against tumour blood-vessel targets, applying its proprietary…
• NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
• 21st.BIO21st.BIO A/S provides precision fermentation technology for proteins and peptides, using microbial strains, fermentation processes, and…
• 3B Pharmaceuticals3B Pharmaceuticals develops targeted radiopharmaceuticals under a targeted radiotherapy program that builds peptide‑based theragnostic and…
• 3H Biomedical3H Biomedical supplies researchers with a broad catalog of primary human and animal cells, purified nucleic acids, cell culture media, and…
• AbbelightAbbelight provides integrated microscopy and nanoscopy instruments, reagents, and analysis software for quantitative bioimaging workflows,…
• Ability PharmaAbility Pharma develops oral targeted anticancer compounds that induce cytotoxic autophagy in cancer cells and advances clinical-stage…
• AACD PharmaACD Pharma develops bacteriophage-based biocontrol products and technologies for preventing and treating bacterial infections, with…
• AciesBioAciesBio provides microbial biotech services for strain engineering, scale-up process design, fermentation-broth processing, contract…